COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE
Yıl: 2021 Cilt: 21 Sayı: 3 Sayfa Aralığı: 494 - 502 Metin Dili: İngilizce DOI: 10.5505/amj.2021.06926 İndeks Tarihi: 18-02-2022
COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE
Öz: Objectives: In this study, we aimed to investigate complementary and alternative medicine (CAM) use and its relationship with adherence to long-term medical therapy in Type 2 Diabetes Mellitus (T2DM). Materials and Methods: The research was designed as a descriptive study. 100 (a hundred) patients who were using oral antidiabetic for at least one year were included in the study. A questionnaire to determine sociodemographic characteristics and CAM use and a six-item Turkish Modified Morisky Scale for the measure of medication adherence were applied to the participants. Results: 55% of patients (n=55) used at least one CAM practice. The most commonly used practice was herbal medicine [80% (n = 44)]. The main reasons for using CAM were to relieve complaints and support their conventional treatment, and 85.5% (n=47) of patients did not consult their physicians about the use of these practices. There was no statistically significant relationship between CAM use and medication adherence. Conclusion: The fact that patients do not consult a doctor while using CAM shows that we need to be careful about toxicities and dose insufficiency due to drug-herb interactions. Physicians should effectively investigate the use of these therapies in addition to the drug history of their patients. Therefore, all physicians should have at least basic knowledge of CAM and learn how to access evidence-based information about these practices.
Anahtar Kelime: TİP 2 DİABETES MELLİTUS’TA TAMAMLAYICI ALTERNATİF TIP KULLANIMI VE TEDAVİ UYUMU İLE İLİŞKİSİ
Öz: Amaç: Bu çalışmada, Tip 2 Diabetes Mellitus’ta (T2DM) tamamlayıcı ve alternatif tıp (TAT) kullanımını ve bunun uzun süreli medikal tedaviye uyum ile ilişkisini araştırmayı amaçladık. Materyal ve Metot: Araştırma, tanımlayıcı tipte bir çalışma olarak tasarlandı. En az 1 yıldır oral antidiyabetik kullanan 100 hasta çalışmaya dahil edildi. Katılımcılara, sosyodemografik özellikleri ve TAT kullanımını sorgulayan bir anket; tedaviye uyumu ölçmek için 6 soruluk Türkçe Modifiye Morisky Ölçeği uygulandı. Bulgular: Hastaların %55’i en az bir TAT yöntemi kullanmıştı. En sık kullanılan yöntem bitkisel ilaçlar (%80(n=44)) idi. TAT yöntemleri başlıca, şikayetleri azaltmak ve tedaviyi destekleyici amaçlı kullanılmış ve hastaların %85,5’i (n=47) bu yöntemlerin kullanımı konusunda doktora danışmamıştı. Bu hastaların %89,4’ü (n=42) danışmama nedenini, ‘doktorun olumsuz tepkisinden çekinme’ olarak belirtti. TAT kullanımı ile tedaviye uyum arasında istatistiksel olarak anlamlı ilişki bulunmadı. Sonuç: Hastaların TAT yöntemlerini kullanırken doktora danışmamaları, ilaç-bitki etkileşimlerine bağlı toksikasyonlara ve doz yetersizliklerine karşı dikkatli olmamız gerektiğini göstermektedir. Hekimler hastalarının ilaç öyküsü yanında bu yöntemlerin kullanımını da etkin bir şekilde sorgulamalıdır. Bu bağlamda, tüm hekimler TAT yöntemleri hakkında temel bilgiye sahip olmalı ve bu tedaviler hakkında kanıta dayalı bilgiye nasıl ulaşılabileceklerini de öğrenmelidir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Şahin A, Dirgar E, Olgun N. Diyabet Yönetiminde Kullanılan Tamamlayıcı ve Alternatif Tedaviler. Diyabet, Obezite ve Hipertansiyonda Hemşirelik Forumu Derg. 2019;11(1):32-6.
- 2. Kesavadev J. Efficacy and safety concerns regarding Complementary and Alternative Medicine use among diabetes patients. JPMA J Pak Med Assoc. 2017;67(2):316-9.
- 3. Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2002;25(2):324-9.
- 4. Lee M-S, Lee MS, Lim H-J, Moon S-R. Survey of the use of complementary and alternative medicine among Korean diabetes mellitus patients. Pharmacoepidemiol Drug Saf. 2004;13(3):167-71 (doi:10.1002/pds.877).
- 5. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep. 2008;(12):1-23.
- 6. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;(2):CD000011 (doi:10.1002/14651858.CD000011).
- 7. Sabaté E, World Health Organization, eds. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
- 8. Osterberg L, Blaschke T. Adherence to Medication. N Engl J Med. 2005;353(5):487-97 (doi:10.1056/NEJMra050100).
- 9. Vural B, Acar ÖT, Topsever P, Filiz TM. Reliability and validity of Turkish version of modified Morisky scale. J Turk Fam Physician. 2012;3(4):17-20.
- 10. Kumar D, Bajaj S, Mehrotra R. Knowledge, attitude and practice of complementary and alternative medicines for diabetes. Public Health. 2006;120(8):705-11 (doi:10.1016/j.puhe.2006.04.010).
- 11. Şahin S. Geleneksel, tamamlayıcı, alternatif tıp uygulamalarına genel bir bakış. Türkiye Aile Hekim Derg. 2017;21(4):159-62 (doi:10.15511/tahd.17.00459).
- 12. Metcalfe A, Williams J, McChesney J, Patten SB, Jetté N. Use of complementary and alternative medicine by those with a chronic disease and the general population - results of a national population based survey. BMC Complement Altern Med. 2010;10(1):58 (doi:10.1186/1472-6882-10-58).
- 13. Calik A. Complementary and alternative treatments used in the treatment of diabetes: literature review. Adnan Menderes Üniversitesi Sağlık Bilim Fakültesi Derg. 2017;1(2):79-84.
- 14. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med. 2006;12(5):16-22.
- 15. Fabian E, Töscher S, Elmadfa I, Pieber TR. Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann Nutr Metab. 2011;58(2):101-108. doi:10.1159/000326765
- 16. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-310 (doi:10.1016/S0149-2918(01)80109-0).
- 17. Cherniack EP. Complementary medicine use is not associated with non-adherence to conventional medication in the elderly: A retrospective study. Complement Ther Clin Pract. 2011;17(4):206-8 (doi:10.1016/j.ctcp.2010.11.005).
- 18. Gohar F, Greenfield SM, Beevers DG, Lip GYH, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med. 2008;8:4 (doi:10.1186/1472- 6882-8-4).
- 19. Bailey GR, Barner JC, Weems JK, et al. Assessing barriers to medication adherence in underserved patients with diabetes in Texas. Diabetes Educ. 2012;38(2):271-279. doi:10.1177/0145721711436134
- 20. Alfian SD, Sukandar H, Arisanti N, Abdulah R. Complementary and alternative medicine use decreases adherence to prescribed medication in diabetes patients. Ann Trop Med Public Health. 2016;9(3):174 (doi:10.4103/1755-6783.179108).
- 21. Lee GBW, Charn TC, Chew ZH, Ng TP. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract. 2004;21(6):654-60 (doi:10.1093/fampra/cmh613).
- 22. Güven ŞD. Diabetus Mellituslu Bireylerin Tamamlayıcı ve Alternatif Tedavi Kullanma Durumları. Nevşehir Bilim Ve Teknol Derg. 2020;9(1):1-8 (doi:10.17100/nevbiltek.694483).
- 23. Payne C. Complementary and Integrative Medicine: Emerging Therapies for Diabetes, Part 1: Preface. Diabetes Spectr. 2001;14(3):129-31 (doi:10.2337/diaspect.14.3.129).
| APA | UYAN C, ALVUR T (2021). COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. , 494 - 502. 10.5505/amj.2021.06926 |
| Chicago | UYAN CEMAL,ALVUR Tuncay Müge COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. (2021): 494 - 502. 10.5505/amj.2021.06926 |
| MLA | UYAN CEMAL,ALVUR Tuncay Müge COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. , 2021, ss.494 - 502. 10.5505/amj.2021.06926 |
| AMA | UYAN C,ALVUR T COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. . 2021; 494 - 502. 10.5505/amj.2021.06926 |
| Vancouver | UYAN C,ALVUR T COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. . 2021; 494 - 502. 10.5505/amj.2021.06926 |
| IEEE | UYAN C,ALVUR T "COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE." , ss.494 - 502, 2021. 10.5505/amj.2021.06926 |
| ISNAD | UYAN, CEMAL - ALVUR, Tuncay Müge. "COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE". (2021), 494-502. https://doi.org/10.5505/amj.2021.06926 |
| APA | UYAN C, ALVUR T (2021). COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. Ankara Medical Journal, 21(3), 494 - 502. 10.5505/amj.2021.06926 |
| Chicago | UYAN CEMAL,ALVUR Tuncay Müge COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. Ankara Medical Journal 21, no.3 (2021): 494 - 502. 10.5505/amj.2021.06926 |
| MLA | UYAN CEMAL,ALVUR Tuncay Müge COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. Ankara Medical Journal, vol.21, no.3, 2021, ss.494 - 502. 10.5505/amj.2021.06926 |
| AMA | UYAN C,ALVUR T COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. Ankara Medical Journal. 2021; 21(3): 494 - 502. 10.5505/amj.2021.06926 |
| Vancouver | UYAN C,ALVUR T COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE. Ankara Medical Journal. 2021; 21(3): 494 - 502. 10.5505/amj.2021.06926 |
| IEEE | UYAN C,ALVUR T "COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE." Ankara Medical Journal, 21, ss.494 - 502, 2021. 10.5505/amj.2021.06926 |
| ISNAD | UYAN, CEMAL - ALVUR, Tuncay Müge. "COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH MEDICATION ADHERENCE". Ankara Medical Journal 21/3 (2021), 494-502. https://doi.org/10.5505/amj.2021.06926 |
